The Lasik Blog

Nidek Seeks Hyperopia Approval from FDA

NIDEK Hyperopia Clinical Study Update & Future FDA Studies -Fremont, CA USA, May 4th, 2004- NIDEK, Inc. announced today that it has completed and submitted 3-month clinical data for its new hyperopia study to the FDA. This marks an important milestone in the study process, as additional treatment eyes will be initiated in the study protocol effective [...]

Continue reading...

Overview of NearVisionSM CK® Fact, Stats &Trivia

One of the Safest and the First FDA Approved Technology for Presbyopic Patients The ViewPoint® CK System, used to perform the NearVision CK treatment, is the first FDA-approved refractive technology for improving the loss of near vision that accompanies presbyopia. The NearVision CK treatment has one of the highest safety profiles in the refractive market thanks to [...]

Continue reading...

NearVisionSM CK® (Conductive Keratoplasty®) Scientific Concept

NearVision CK is the first vision treatment specifically for baby boomers who want freedom from their reading glasses. CK is performed using the ViewPoint® CK System; the first FDA-approved technology for improving near vision in presbyopic patients. Nearly 90 million baby boomers have or will soon develop presbyopia, the most common eye condition in [...]

Continue reading...